Literature DB >> 6887353

Renal cell carcinoma: the Ochsner Medical Institution experience (1945-1978).

H A Fuselier, S L Guice, W Brannan, M G Ochsner, K V Sangisetty, E N Beckman, C A Barnes.   

Abstract

We reviewed 161 patients operated upon for renal cell carcinoma between 1945 and 1978. Life table and survival analyses were computed to compare the effects of stage, tumor differentiation, cell type, surgical technique, renal vein involvement and sex on the years of survival. Patients with stage I and well differentiated tumors had the best prognosis. All patients surviving 10 years or more had well differentiated tumors. The type of nephrectomy did not affect survival and lymphadenectomy was only of value in staging the disease. The stage and differentiation of the tumor were more important to outcome than choice of therapy.

Entities:  

Mesh:

Year:  1983        PMID: 6887353     DOI: 10.1016/s0022-5347(17)51243-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Pancreatic metastases of renal cell carcinoma: report of two cases.

Authors:  S P Strijk
Journal:  Gastrointest Radiol       Date:  1989

2.  Prognostic index of renal carcinomas.

Authors:  D L Répássy
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

3.  Transperitoneal laparoscopic adrenalectomy for metachronous contralateral adrenal metastasis from renal cell carcinoma: a case report.

Authors:  Evangelos Zacharakis; Maria J Ribal; Emmanouil Zacharakis; Hiten Rh Patel
Journal:  Cases J       Date:  2008-09-26

Review 4.  Solitary brain metastasis 13 years after removal of renal adenocarcinoma.

Authors:  M Ammirati; M Samii; G Skaf; A Sephernia
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

5.  Hypophyseal metastatic hypernephroma mimicking a pituitary adenoma. Case report.

Authors:  S Nishio; H Tsukamoto; M Fukui; T Matsubara
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.